Timothy Lyons

Title: Innovations by Timothy Lyons in Preeclampsia Detection

Introduction

Timothy Lyons is an accomplished inventor based in Belfast, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of preeclampsia. His innovative work focuses on the use of biomarkers to predict the risk of this serious condition in pregnant women.

Latest Patents

Timothy Lyons holds a patent for a groundbreaking invention titled "Biomarker for Preeclampsia." This invention relates to the use of the biomarker LRG1 as a predictive tool for preeclampsia from the first trimester of pregnancy. Elevated levels of leucine-rich alpha 2 glycoprotein 1 (LRG1) can indicate the risk of developing preeclampsia or other hypertensive disorders during pregnancy. The predictive test involves measuring LRG1 protein, peptide fragments, DNA, or RNA from various biological samples, including blood, plasma, serum, urine, saliva, or amniotic fluid. This invention provides a method and a test kit to assess the risk of preeclampsia in pregnant women, utilizing antibodies to measure levels of LRG1 in a sample.

Career Highlights

Timothy Lyons is affiliated with The Queen's University of Belfast, where he conducts research and develops innovative solutions in the field of maternal health. His work has garnered attention for its potential to improve outcomes for pregnant women and their babies.

Collaborations

Some of Timothy's notable coworkers include Chris Watson and Alice Cheung, who contribute to the collaborative efforts in research and development at The Queen's University of Belfast.

Conclusion

Timothy Lyons is a pioneering inventor whose work on biomarkers for preeclampsia has the potential to transform prenatal care. His contributions to medical diagnostics highlight the importance of innovation in improving health outcomes for mothers and their children.